Evidence map›Paper›PMID 34737875›Full record

ArticleRoyal Society open science2021

Modelling the impact of age-stratified public health measures on SARS-CoV-2 transmission in Canada.

Vanessa Gabriele-Rivet, Kelsey L Spence, Nicholas H Ogden, Aamir Fazil, Patricia Turgeon, Ainsley Otten, Lisa A Waddell, Victoria Ng

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  4. Review
  5. Article
  6. Counterfactuals of effects of vaccination and public health measures on COVID-19 cases in Canada: What could have happened?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vanessa Gabriele-RivetPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.ORCID 0000-0003-0813-7100
Kelsey L SpenceDepartment of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Nicholas H OgdenPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.ORCID 0000-0002-1062-7283
Aamir FazilPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.
Patricia TurgeonPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.
Ainsley OttenPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.
Lisa A WaddellPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.
Victoria NgPublic Health Risk Sciences Division, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ontario and St-Hyacinthe, Québec, Canada.ORCID 0000-0002-7619-541X
Public Health Agency of Canada · CAUniversity of Guelph · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public health measures applied exclusively within vulnerable populations have been suggested as an alternative to community-wide interventions to mitigate SARS-CoV-2 transmission. With the population demography and healthcare capacity of Canada as an example, a stochastic age-stratified agent-based model was used to explore the progression of the COVID-19 epidemic under three intervention scenarios (infection-preventing vaccination, illness-preventing vaccination and shielding) in individuals above three age thresholds (greater than or equal to 45, 55 and 65 years) while lifting shutdowns and physical distancing in the community. Compared with a scenario with sustained community-wide measures, all age-stratified intervention scenarios resulted in a substantial epidemic resurgence, with hospital and ICU bed usage exceeding healthcare capacities even at the lowest age threshold. Individuals under the age threshold were severely impacted by the implementation of all age-stratified interventions, with large numbers of avoidable deaths. Among all explored scenarios, shielding older individuals led to the most detrimental outcomes (hospitalizations, ICU admissions and mortality) for all ages, including the targeted population. This study suggests that, in the absence of community-wide measures, implementing interventions exclusively within vulnerable age groups could result in unmanageable levels of infections, with serious outcomes within the population. Caution is therefore warranted regarding early relaxation of community-wide restrictions.

Indexed as

agent-based modelage-stratified interventionsCanadaCOVID-19Great Barrington Declarationvaccination

Identifiers

PMID34737875
PMCPMC8562391
OpenAlexW3209065477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.